Literature DB >> 9439761

Immunopathogenesis of herpetic ocular disease.

J Thomas1, B T Rouse.   

Abstract

Herpes viruses are among the most prevalent of human virus infections. Productive replication of herpes simplex virus (HSV) is usually confined to mucocutaneous sites by the rapid deployment of innate and adaptive immune responses. Infection invariably results in establishment of latency and in some cases results in periodic reactivation of the virus. This article focuses primarily on ocular herpes with emphasis on the pathogenesis of stromal keratitis. Herpetic stromal keratitis (HSK) is an immunopathologic disease, which indeed is one of the leading causes of blindness in the Western world. The mechanisms by which HSV infection in human beings results in HSK is not well understood but studies using the mouse model has clearly indicated the role of T-cell-mediated immune response as the cause for ocular damage. We, in this article, attempt to provide an interpretive synthesis on different aspects of HSK pathogenesis, reviewing what is currently known and speculating on mysterious issues, such as, whether HSK represents a virus-induced autoimmune disease. We also discuss aspects of remission of the disease.

Entities:  

Mesh:

Year:  1997        PMID: 9439761     DOI: 10.1007/BF02786400

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  63 in total

Review 1.  Nitric oxide synthases: roles, tolls, and controls.

Authors:  C Nathan; Q W Xie
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

Review 2.  Mechanisms of neutrophil-induced parenchymal cell injury.

Authors:  H Jaeschke; C W Smith
Journal:  J Leukoc Biol       Date:  1997-06       Impact factor: 4.962

3.  Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10.

Authors:  M Daheshia; N Kuklin; S Kanangat; E Manickan; B T Rouse
Journal:  J Immunol       Date:  1997-08-15       Impact factor: 5.422

4.  On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis.

Authors:  J Thomas; S Gangappa; S Kanangat; B T Rouse
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

Review 5.  The virology and immunobiology of lymphocytic choriomeningitis virus infection.

Authors:  M J Buchmeier; R M Welsh; F J Dutko; M B Oldstone
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

Review 6.  Cytokines in autoimmunity.

Authors:  F M Brennan; M Feldmann
Journal:  Curr Opin Immunol       Date:  1996-12       Impact factor: 7.486

7.  Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.

Authors:  M Yasukawa; J M Zarling
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

8.  Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection.

Authors:  Y H Su; X T Yan; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide.

Authors:  A C Avery; Z S Zhao; A Rodriguez; E K Bikoff; M Soheilian; C S Foster; H Cantor
Journal:  Nature       Date:  1995-08-03       Impact factor: 49.962

10.  Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice.

Authors:  D M Bouley; S Kanangat; W Wire; B T Rouse
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

View more
  47 in total

1.  Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice.

Authors:  S P Deshpande; M Zheng; M Daheshia; B T Rouse
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.

Authors:  Aaron W Kolb; Timothy R Schmidt; David W Dyer; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

3.  Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1.

Authors:  Sabine Vollstedt; Susi Arnold; Cornelia Schwerdel; Marco Franchini; Gottfried Alber; James P Di Santo; Mathias Ackermann; Mark Suter
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  Age-related dysregulation of CD8+ T cell memory specific for a persistent virus is independent of viral replication.

Authors:  Anna Lang; James D Brien; Ilhem Messaoudi; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

5.  Using HSV-1 genome phylogenetics to track past human migrations.

Authors:  Aaron W Kolb; Cécile Ané; Curtis R Brandt
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

6.  Herpes Simplex Virus 1 ICP22 Suppresses CD80 Expression by Murine Dendritic Cells.

Authors:  Harry Matundan; Homayon Ghiasi
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

7.  Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis.

Authors:  Bumseok Kim; Qingquan Tang; Partha S Biswas; Jun Xu; Raymond M Schiffelers; Frank Y Xie; Aslam M Ansari; Puthupparampil V Scaria; Martin C Woodle; Patrick Lu; Barry T Rouse
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo.

Authors:  Patric Lundberg; Paula Welander; Xiao Han; Edouard Cantin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Curcumin inhibits angiogenesis by up-regulation of microRNA-1275 and microRNA-1246: a promising therapy for treatment of corneal neovascularization.

Authors:  Yanhui Bai; Weiqun Wang; Guangli Sun; Mingchang Zhang; Jingmin Dong
Journal:  Cell Prolif       Date:  2016-09-14       Impact factor: 6.831

10.  CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis.

Authors:  Fangli Lu; Shiguang Huang; Lloyd H Kasper
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.